Over ⅓ of all deaths globally are stress and cardiovascular disease related. Approximately 86 million people in the US have at least one type of cardiovascular disease and over 735K Americans have a heart attack annually – Over 210K are repeats. The cost of treating heart failure in the U.S.  is expected to reach $70B by 2030 from about $30 billion today.

310 Million Wearable Devices Sold in 2017

Why have we not been able to move the needle yet when it comes to the at risk population?

Resting patients, standardized temperatures and humidity: A hospital/clinical setting provides a stable environment for existing devices to gather clinically viable data. Remote monitoring is very different from a hospital setting. Acquiring clinically valuable data in motion, recognizing early warning signs, alerting the patient, caregivers and/or calling first responders is a big challenge requiring a wider array of sensors, on-the-go measurements, more complicated electronic schematics and more flexible algorithms. On a mountain trail, in a fighter jet cockpit, or running a marathon, “normal” is a variable – not a constant. We need a much deeper understanding of an individual’s physical and emotional states and changes to accurately assess risk and adaptability.

Screen Shot 2018-11-29 at 9.30.19 PM

Devali is combing multiple proprietary sensors and adjustable algorithms into comfortable garment-based devices with multiple user interfaces to track, monitor and study biometric and physiological performance data, changes in body homeostasis and measure the impact of internal and external stressors on the entire human system in motion. By tracking changes over time, comparing against existing clinical data and using machine learning for predictive analysis and event modeling, our overarching long-term goal is to learn to predict and prevent heart attacks and strokes. In the meantime, we are on a mission to save lives at every step along the way.